These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 25411345)

  • 1. Metastases in immune-mediated dormancy: a new opportunity for targeting cancer.
    Romero I; Garrido F; Garcia-Lora AM
    Cancer Res; 2014 Dec; 74(23):6750-7. PubMed ID: 25411345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T lymphocytes restrain spontaneous metastases in permanent dormancy.
    Romero I; Garrido C; Algarra I; Collado A; Garrido F; Garcia-Lora AM
    Cancer Res; 2014 Apr; 74(7):1958-68. PubMed ID: 24531750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor dormancy and immunoescape.
    Quesnel B
    APMIS; 2008; 116(7-8):685-94. PubMed ID: 18834412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
    Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine-Based Immunotherapy for the Treatment of Cancer Metastasis.
    Zhang P; Zhai Y; Cai Y; Zhao Y; Li Y
    Adv Mater; 2019 Dec; 31(49):e1904156. PubMed ID: 31566275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antitumor immunity and cellular cancer therapies].
    Catros-Quemener V; Bouet F; Genetet N
    Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
    Arancia G; Malorni W; Donelli G
    Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour MHC class I downregulation and immunotherapy (Review).
    Bubeník J
    Oncol Rep; 2003; 10(6):2005-8. PubMed ID: 14534734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8-interaction mutant HLA-Cw3 molecules protect porcine cells from human natural killer cell-mediated antibody-dependent cellular cytotoxicity without stimulating cytotoxic T lymphocytes.
    Sharland A; Lee JH; Saidman S; Waneck GL
    Transplantation; 2003 Dec; 76(11):1615-22. PubMed ID: 14702534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells.
    Tu MM; Mahmoud AB; Wight A; Mottashed A; Bélanger S; Rahim MM; Abou-Samra E; Makrigiannis AP
    Cancer Res; 2014 Jul; 74(14):3684-94. PubMed ID: 24802191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer dormancy. VII. A regulatory role for CD8+ T cells and IFN-gamma in establishing and maintaining the tumor-dormant state.
    Farrar JD; Katz KH; Windsor J; Thrush G; Scheuermann RH; Uhr JW; Street NE
    J Immunol; 1999 Mar; 162(5):2842-9. PubMed ID: 10072532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour dormancy: initiation, maintenance and termination in animals and humans.
    Stewart TH; Hollinshead AC; Raman S
    Can J Surg; 1991 Aug; 34(4):321-5. PubMed ID: 1868387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer immune escape: MHC expression in primary tumours versus metastases.
    Garrido F; Aptsiauri N
    Immunology; 2019 Dec; 158(4):255-266. PubMed ID: 31509607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bench to bedside: NK cells and control of metastasis.
    Krasnova Y; Putz EM; Smyth MJ; Souza-Fonseca-Guimaraes F
    Clin Immunol; 2017 Apr; 177():50-59. PubMed ID: 26476139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor dormancy: long-term survival in a hostile environment.
    Quesnel B
    Adv Exp Med Biol; 2013; 734():181-200. PubMed ID: 23143980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of microRNAs in the control of innate immune response in cancer.
    Jasinski-Bergner S; Mandelboim O; Seliger B
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25217579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inherent premise of immunotherapy for cancer dormancy.
    Manjili MH
    Cancer Res; 2014 Dec; 74(23):6745-9. PubMed ID: 25411346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of intratumoral IL-12 and TNF-alpha microspheres: systemic anti-tumor immunity is mediated by both CD8+ CTL and NK cells.
    Sabel MS; Arora A; Su G; Mathiowitz E; Reineke JJ; Chang AE
    Surgery; 2007 Nov; 142(5):749-60. PubMed ID: 17981196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of Metastasis by NK Cells.
    López-Soto A; Gonzalez S; Smyth MJ; Galluzzi L
    Cancer Cell; 2017 Aug; 32(2):135-154. PubMed ID: 28810142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of cellular immune response by Ipomoea obscura and Ipobscurine alkaloid attenuates tumor growth in mice.
    Hamsa TP; Kuttan G
    Can J Physiol Pharmacol; 2011 Apr; 89(4):259-68. PubMed ID: 21539469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.